Prosecution Insights
Last updated: April 19, 2026

Examiner: AL-AWADI, DANAH J

Tech Center 1600 • Art Units: 1615

This examiner grants 53% of resolved cases

Performance Statistics

53.2%
Allow Rate
-6.8% vs TC avg
836
Total Applications
+14.3%
Interview Lift
1195
Avg Prosecution Days
Based on 795 resolved cases, 2023–2026

Rejection Statute Breakdown

2.7%
§101 Eligibility
15.1%
§102 Novelty
46.9%
§103 Obviousness
20.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19298695 SOLID LIPID NANOPARTICLES FOR ENCAPSULATION AND DELIVERY OF BIOACTIVE COMPOUNDS AND METHODS OF MAKING THE SAME Non-Final OA Yubeck, Inc.
18543618 ECOFRIENDLY COMPOSITIONS CONTAINING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE Non-Final OA L'OREAL
18518099 EYELASH COATING COMPOSITIONS FOR FALSE EYELASHES Final Rejection L'OREAL
17363624 LIPSTICKS HAVING NATURAL OIL, FATTY ALCOHOL WAX AND FILLER PARTICLES Non-Final OA L'OREAL
18528873 NANOPARTICLE (NP) COMPOSITIONS AND METHODS OF USE THEREOF Non-Final OA RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
18032201 HYDROPHOBIC DRUGS IN ORGANIC CORE HIGH DENSITY LIPOPROTEIN (HDL) NANOPARTICLES Non-Final OA CITY OF HOPE
18299135 ON DEMAND AND LONG-TERM DRUG DELIVERY FROM DEGRADABLE NANOCAPSULES Non-Final OA University of Maryland, Baltimore County
18268650 Make-up Composition With Gloss and Lasting Properties Final Rejection L V M H RECHERCHE
18269543 FATTY ACID-MODIFIED POLYMER NANOPARTICLES, AND USE THEREOF Non-Final OA SUPERNOVA BIO CO., LTD.
18269083 Formulations, Biodegradable Membranes, Products Including Biodegradable Membranes, and Methods of Manufacture Non-Final OA SLEAKTEK LIMITED
18268263 COMPOSITIONS FOR REDUCING METHANE EMISSION, METHODS FOR IMPROVING THE METABOLIC EFFICIENCY OF RUMINANT ANIMALS AND METHANOGENESIS INHIBITOR ADMINISTRATION Final Rejection MOOTRAL INNOVATIONS LIMITED
18250459 METHODS AND COMPOSITIONS FOR NUTRITIONAL SUSTENANCE AND WASTE SCAVENGING IN TISSUE INJURIES AND WOUNDS Non-Final OA New York Society for the Relief of the Ruptured and Crippled, Maintaining the Hospital For Special
18036482 ORALLY DISPERSIBLE COMPOUND CONTAINING AN ESTER OR SALT OF N-BUTYRIC ACID AND PROCESS FOR PRODUCTION Non-Final OA SILA SRL
17784325 STABILIZATION OF SELENITE IN A NUTRITIONAL SOLUTION BY DISSOLVED OXYGEN Final Rejection BAXTER HEAL THCARE SA
17640625 PHARMACEUTICAL COMPOSITION Final Rejection Renown Pharma Inc.
17277400 Flutamide Microsphere-Based Arterial Embolization for Treating Prostate Disorders Final Rejection Biovena Science, LLC
17270353 LIPOFULLERENE CONJUGATES AND THEIR USE FOR PROMOTION OF HAIR GROWTH AND PREVENTION OF HAIR LOSS Final Rejection LivePet, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month